COVID-19 and cardiovascular problems in elderly patients: Food for thought
- PMID: 33821229
- PMCID: PMC8014783
- DOI: 10.1002/agm2.12149
COVID-19 and cardiovascular problems in elderly patients: Food for thought
Abstract
The global number of COVID-19 infections, as of December 23, 2020, stood at approximately 79 million, with over 1.7 million deaths. The development of vascular inflammation may also contribute to a hypercoagulable state and endothelial dysfunction in such patients. It is known that multi-organ damage is more likely in patients with sepsis if they develop coagulopathy and that inhibition of thrombin synthesis can have a positive impact in reducing mortality. In this review, we will focus on the protection of the most fragile groups of the population, such as the elderly. This segment of the population will be a key issue and probably of primary interest to all. Biomarkers appear to be extremely useful as an indicator of what is happening from a pathophysiological point of view in the heart, allowing us to better stratify the prognosis of our patients affected by COVID-19, especially in the most severe cases and those with comorbidities.
Keywords: COVID‐19; cardiovascular patients; elderly.
© 2021 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors report no competing interests.
Similar articles
-
Hemostasis and endothelial damage during sepsis.Dan Med J. 2015 Aug;62(8):B5135. Dan Med J. 2015. PMID: 26239597
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.Saudi J Biol Sci. 2022 May;29(5):3586-3599. doi: 10.1016/j.sjbs.2022.02.006. Epub 2022 Feb 10. Saudi J Biol Sci. 2022. PMID: 35165505 Free PMC article. Review.
-
Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.Health Technol Assess. 2021 Jun;25(39):1-74. doi: 10.3310/hta25390. Health Technol Assess. 2021. PMID: 34142943 Free PMC article.
-
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357. doi: 10.1080/14787210.2020.1822737. Epub 2020 Sep 28. Expert Rev Anti Infect Ther. 2021. PMID: 32921216 Review.
Cited by
-
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study.J Clin Med. 2022 Oct 17;11(20):6121. doi: 10.3390/jcm11206121. J Clin Med. 2022. PMID: 36294442 Free PMC article.
-
Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems.Front Physiol. 2022 Jan 14;12:748972. doi: 10.3389/fphys.2021.748972. eCollection 2021. Front Physiol. 2022. PMID: 35095546 Free PMC article. Review.
-
Older adults: panoramic view on the COVID-19 vaccination.AIMS Public Health. 2021 May 8;8(3):388-415. doi: 10.3934/publichealth.2021030. eCollection 2021. AIMS Public Health. 2021. PMID: 34395690 Free PMC article. Review.
References
-
- World Health Organization WHO Director‐General's opening remarks at the media briefing on COVID‐19‐11 March 2020. https://www.who.int/dg/speeches/detail/whodirector‐general‐s‐opening‐rem.... Accessed March 12, 2020.
-
- United Nations . World population prospects 2019. New York, NY: United Nations. https://population.un.org/wpp/. Accessed December 21, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources